Research Article
Clinical Efficacy of Antianlotinib Combined with Immune Checkpoint Inhibitors in the Treatment of Advanced Non-Small-Cell Lung Cancer and Its Effect on Serum VEGF, CEA, and SCC-Ag
Table 3
T lymphocyte subsets and serum level of vascular endothelial growth factor before and after therapy.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
, compared with the control group; #, compared with before treatment. |